RecruitingNCT06595160

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma Patients


Sponsor

Emory University

Enrollment

87 participants

Start Date

Aug 5, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study explores the relationship between pre-treatment dietary patterns, fecal microbiome, and response to chemotherapy in patients with pancreatic ductal adenocarcinoma.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether a patient's gut bacteria (microbiome) and dietary habits influence how well they respond to chemotherapy before surgery for pancreatic ductal adenocarcinoma (a type of pancreatic cancer). **You may be eligible if...** - You are 18 or older - You have been diagnosed with pancreatic ductal adenocarcinoma (confirmed by biopsy or tissue testing) - Your cancer is resectable (operable) or borderline resectable based on imaging - You have signed informed consent **You may NOT be eligible if...** - Your cancer is locally advanced or has spread to other organs (stage IV) - You have already started or completed neoadjuvant (pre-surgery) chemotherapy for this cancer - You have another active cancer currently being treated with systemic therapy Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNon-Interventional Study

Non-interventional study


Locations(1)

Emory University Hospital/Winship Cancer Institute

Atlanta, Georgia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06595160


Related Trials